IRIS
ZANABONI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.688
AS - Asia 995
EU - Europa 710
SA - Sud America 210
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 61
OC - Oceania 4
Totale 3.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.612
CN - Cina 349
SG - Singapore 294
IE - Irlanda 182
BR - Brasile 167
HK - Hong Kong 133
RU - Federazione Russa 125
VN - Vietnam 114
IT - Italia 110
DE - Germania 101
FR - Francia 48
ZA - Sudafrica 45
CA - Canada 32
FI - Finlandia 29
GB - Regno Unito 29
MX - Messico 18
AR - Argentina 14
AT - Austria 14
IN - India 14
BD - Bangladesh 11
PL - Polonia 11
ID - Indonesia 10
IQ - Iraq 10
SE - Svezia 10
ES - Italia 9
JP - Giappone 8
CO - Colombia 7
EC - Ecuador 7
NL - Olanda 7
UA - Ucraina 7
PH - Filippine 6
TR - Turchia 6
UZ - Uzbekistan 6
BE - Belgio 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
MA - Marocco 5
PK - Pakistan 5
VE - Venezuela 5
GP - Guadalupe 4
LT - Lituania 4
SA - Arabia Saudita 4
AU - Australia 3
IL - Israele 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
SV - El Salvador 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PR - Porto Rico 2
PY - Paraguay 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 3.669
Salva come PNG Salva come JPEG
Città #
San Jose 183
Dublin 182
Chandler 168
Ashburn 165
Singapore 137
Hong Kong 129
Council Bluffs 101
Beijing 91
Dallas 89
Boardman 71
Munich 59
Johannesburg 41
Lauterbourg 37
Nanjing 33
Los Angeles 32
Ho Chi Minh City 30
Redondo Beach 29
Hanoi 27
Santa Clara 27
New York 26
Shanghai 26
Lawrence 25
Medford 24
Princeton 24
Moscow 23
Jacksonville 18
São Paulo 18
Buffalo 16
Changsha 15
Atlanta 14
Frankfurt am Main 14
Nanchang 14
Orem 14
Wilmington 14
The Dalles 13
Rome 12
Turku 12
Hebei 11
Helsinki 11
Jiaxing 11
Ann Arbor 10
Brooklyn 10
North Bergen 10
Phoenix 10
Warsaw 10
Hangzhou 9
Milan 9
Shenyang 9
Turin 9
Chicago 8
Da Nang 8
Düsseldorf 8
Haiphong 8
Nuremberg 8
Tokyo 8
Washington 8
Belo Horizonte 7
Mexico City 7
Montreal 7
Pavia 7
Toronto 7
Columbus 6
Denver 6
Guangzhou 6
London 6
Porto Alegre 6
Rio de Janeiro 6
Seattle 6
Brussels 5
Can Tho 5
Charlotte 5
Naples 5
Orlando 5
San Francisco 5
Tashkent 5
Tianjin 5
Baghdad 4
Brasília 4
Brno 4
Campinas 4
Guatemala City 4
Ninh Bình 4
Norwalk 4
Poplar 4
Vienna 4
Amsterdam 3
City of London 3
Cuiabá 3
Dhaka 3
Erbil 3
Guayaquil 3
Houston 3
Jinan 3
Managua 3
Manchester 3
Muscat 3
Newark 3
Palermo 3
Querétaro 3
Redwood City 3
Totale 2.326
Salva come PNG Salva come JPEG
Nome #
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 158
Blocco combinato di coattivazione e costimolazione: una strategia utile nell'induzione di tolleranza alloantigene - specifica 135
Endocannabinoid system and migraine pain: An update 121
Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury 119
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine 118
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 117
Microarray analysis on peripheral blood mononuclear cells of coeliac patients 116
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 113
Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing 111
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model 110
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 109
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings 108
Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients 108
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 108
Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine 99
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine? 98
Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back 98
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study 98
A Narrative Review of Intestinal Microbiota's Impact on Migraine with Psychopathologies 97
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 97
Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: Study in an animal model 96
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks 96
Microarray analysis of peripheral blood mononuclear cells in coeliac disease 95
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 94
The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain 94
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 91
Dual inhibition of faah and magl counteracts migraine-like pain and behavior in an animal model of migraine 90
Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches 90
Cd163 as a potential biomarker of monocyte activation in ischemic stroke patients 87
URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia 78
Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study 78
Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine 77
Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine 76
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? 72
Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia 69
Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis 67
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine 67
Modelling migraine-related features in the nitroglycerin animal model: Trigeminal hyperalgesia is associated with affective status and motor behavior 61
Insights into the Involvement of TRPA1 Channels in the Neuro-Inflammatory Machinery of Trigeminal Neuralgia 10
Exploring the Association of Migraine Susceptibility SNPs With the Risk of Chronic Migraine 9
Totale 3.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022104 0 0 0 0 0 1 3 9 3 2 14 72
2022/2023442 34 21 19 33 31 49 0 30 204 3 13 5
2023/2024195 22 21 8 13 14 39 1 13 3 8 22 31
2024/2025735 18 38 16 16 35 61 85 35 197 40 67 127
2025/20261.569 134 85 162 146 198 66 285 91 187 110 68 37
2026/2027448 19 85 89 163 92 0 0 0 0 0 0 0
Totale 3.735